Medication safety
AI Geriatric Medication Safety for Older Adults, LTC & Hospice
Medroxa Geriatric Safety helps pharmacists review medication regimens for older adults with attention to Beers Criteria and STOPP-style safety themes across ambulatory, long-term care (LTC), and hospice settings. Provide the medication list and relevant geriatric context to receive a structured safety draft. Results are clinical decision support only and must be verified by a licensed clinician against institutional protocols and current criteria publications.
The challenge
Polypharmacy in older adults creates high interaction, fall, anticholinergic, and deprescribing complexity. Criteria lists are dense, and LTC/hospice goals of care change the risk-benefit calculus.
How AI Geriatric Safety (Beers Criteria) | LTC | Hospice helps
Medroxa structures geriatric risk themes and discussion points so pharmacists can prioritize high-yield interventions during MTM, LTC rounds, or hospice medication review.
Clinical use cases
- Comprehensive MTM for adults 65+
- LTC consultant pharmacist monthly reviews
- Hospice medication appropriateness discussions
- Pairing with Deprescribing Plan and Drug Interactions
Typical workflow
- Enter the medication list and geriatric care setting context.
- Generate the Beers/STOPP-oriented safety draft.
- Prioritize interventions with the care team and verify against current criteria.
Related clinical tools
Frequently asked questions
- Does this replace official Beers Criteria documents?
- No. Use primary criteria publications and facility protocols as the source of truth.
- Are hospice goals of care considered?
- Provide care-setting context in your inputs. Clinicians must still align recommendations with patient goals and palliative priorities.
Clinical content oversight
Medroxa marketing and tool pages are written to help licensed pharmacists and prescribers evaluate clinical decision-support workflows. Content is produced by the Medroxa Clinical Informatics Team using product documentation and pharmacist advisory review — not anonymous SEO churn.
- Content author
- Medroxa Clinical Informatics Team
- Clinical reviewer
- Licensed pharmacist advisory panel (periodic review)
- Last reviewed
